Ravaux I - Search Results

1

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group. Chéret A, et al. Among authors: ravaux i. Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18. Lancet Infect Dis. 2015. PMID: 25701561 Clinical Trial.

2

TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load.

Touinssi M, Gallian P, Biagini P, Attoui H, Vialettes B, Berland Y, Tamalet C, Dhiver C, Ravaux I, De Micco P, De Lamballerie X. Touinssi M, et al. Among authors: ravaux i. J Clin Virol. 2001 May;21(2):135-41. doi: 10.1016/s1386-6532(01)00157-3. J Clin Virol. 2001. PMID: 11378494

3

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.

Colson P, Ravaux I, Yahi N, Tourrès C, Gallais H, Tamalet C. Colson P, et al. Among authors: ravaux i. AIDS. 2002 Feb 15;16(3):507-9. doi: 10.1097/00002030-200202150-00034. AIDS. 2002. PMID: 11834974 No abstract available.

4

Genomic and phylogenetic analysis of hepatitis C virus isolates: a survey of 535 strains circulating in southern France.

Tamalet C, Colson P, Tissot-Dupont H, Henry M, Tourres C, Tivoli N, Botta D, Ravaux I, Poizot-Martin I, Yahi N. Tamalet C, et al. Among authors: ravaux i. J Med Virol. 2003 Nov;71(3):391-8. doi: 10.1002/jmv.10505. J Med Virol. 2003. PMID: 12966544

5

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, Allegre T, Mokhtari M, Moreau J, Lepeu G, Petit N, Durand A, Lacarelle B. Solas C, et al. Among authors: ravaux i. Br J Clin Pharmacol. 2004 Apr;57(4):436-40. doi: 10.1046/j.1365-2125.2003.02020.x. Br J Clin Pharmacol. 2004. PMID: 15025741 Free PMC article.

6

Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome.

Henry M, Tourres C, Colson P, Ravaux I, Poizot-Martin I, Tamalet C. Henry M, et al. Among authors: ravaux i. J Clin Virol. 2006 Nov;37(3):227-30. doi: 10.1016/j.jcv.2006.07.001. Epub 2006 Aug 22. J Clin Virol. 2006. PMID: 16931138

7

The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.

Solas C, Colson P, Ravaux I, Poizot-Martin I, Moreau J, Lacarelle B, Tamalet C. Solas C, et al. Among authors: ravaux i. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):177-80. doi: 10.1097/QAI.0b013e318164226a. J Acquir Immune Defic Syndr. 2008. PMID: 18197119

8

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.

Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P, Mahamat A, Rabaud C, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV. Grabar S, et al. HIV Med. 2008 Apr;9(4):246-56. doi: 10.1111/j.1468-1293.2008.00554.x. HIV Med. 2008. PMID: 18366449 Free article.

9

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.

Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D, Mary-Krause M; FHDH-ANRS CO 4. Piketty C, et al. AIDS. 2008 Jun 19;22(10):1203-11. doi: 10.1097/QAD.0b013e3283023f78. AIDS. 2008. PMID: 18525266

10

Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.

Solas C, Gagnieu MC, Ravaux I, Drogoul MP, Lafeuillade A, Mokhtari S, Lacarelle B, Simon N. Solas C, et al. Among authors: ravaux i. Ther Drug Monit. 2008 Dec;30(6):670-3. doi: 10.1097/FTD.0b013e3181897bff. Ther Drug Monit. 2008. PMID: 18806695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters